CGTLive®'s Weekly Rewind – September 6, 2024
CGTLive®’s Weekly Rewind highlights 5 gene and cell therapy advances: therapy for HLA-DRB1*15:01 positive progressive MS patients, newborn screening enhancements, GT201 IND clearance in China, 85% reduction in HS D2S6 levels in CSF, and data from the DEVOTE trial.
Highlighted Terms
Related News
CGTLive®'s Weekly Rewind – September 6, 2024
CGTLive®’s Weekly Rewind highlights 5 gene and cell therapy advances: therapy for HLA-DRB1*15:01 positive progressive MS patients, newborn screening enhancements, GT201 IND clearance in China, 85% reduction in HS D2S6 levels in CSF, and data from the DEVOTE trial.